Examining The Impact of Voluntary Restricted Distribution Systems in the Pharmaceutical Supply Chain. 3.22.17.
I got a few ideas. To solve both the companies' issues about cost of development of new drugs and profit margins and complaints from patients who need the drugs.
1) Let the bidding for Medicare pricing be open so that the rest of the market (competitors, insurance companies, generic drug mfgs, other countries' markets, and end-users/patients can see it.)
2) Make it illegal to directly market to end-users prescription drugs (or any drug maybe*) and marketing only by post to doctors.# That would cut most the "marketing" costs for those companies, which instead could be used to reinvestment in new drugs or returned as dividends to shareholders. No more TV ads demanding you ask your doctor about a drug for a problem you likely don't have.
3) Pass some law indemnifying, or placing some caps on damages, or some such scheme for the companies who release a patented new medicine to other companies for generic mfg against any lawsuits etc. That eliminates much of the companies' REM "concern." This could be some kind of risk pool between the mfg's or a law like we do with certain vaccines.
4) they/he should redact the personal information on the documents presented. At least black out addresses and/or personal information but show the pricing differentials etc. What is it our government doesn't "get" about securing personal information?
5) Require that all doctors, hospitals, and pharmacists ask "patient," when possible, if you want the generic drugs.
6) Better oversight and testing for all drugs, especially those made overseas, and especially for cheap generic made by foreign companies. Even after their efficacy is known. I don't want "fake drugs," or worse, coming in as generic drugs that could harm patients.
*1) 1st Amendment you say? Ok, instead of passing a law against pass a law giving treble damages (or more)above any judgement, or settlement, for any successful lawsuit against a drug that was marketed directly to the end-user in television, internet, radio, mail, or print.
#2) Ok, some former University of Kentucky cheerleaders and sales
will have to find a new job. Too bad, but, luckily for them looking good and being a good salesperson can almost always find you a job. Maybe not as lucrative but there is always places for good salespeople. But that is how my doctor gets me "free samples" you say? True but those "free samples" are coming at a larger cost to the system. Plus I would allow actual scientific conferences on new drugs (but not just golf and fishing trip to learn about the new pill) and sample to be sent with literature but to doctors only. And advertising, of a scientific/medical nature, in the trade publications.